Figure 7.
Univariate and multivariate analyses of the GC-MS metabolites. A, PCA of primary metabolites/features of compound-treated and untreated control samples. Control (black), WD30030 (red), compound WD20542 (cyan), compound WD10461 (blue), compound WD20067 (green), and compound WD10784 (pink) are indicated. B, PLS-DA of the data for better separation of the samples to identify features that are responsible for differentiation in the treatment. C, Top 20 metabolites with significantly different abundance between compound treatments based on the VIP deduced using the Metaboanalyst Web tool (http://www.metaboanalyst.ca).